Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd ( (AU:4DX) ) has issued an announcement.
4DMedical Ltd has applied for quotation on the ASX of a total of 938,175 new fully paid ordinary shares, issued in two tranches on 27 March 2026 and 2 April 2026. The additional shares, arising from the exercise or conversion of existing options or other convertible securities, will expand the company’s listed capital base and may modestly enhance liquidity for investors once trading commences.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian medical technology company listed on the ASX under the code 4DX. The company focuses on advanced respiratory imaging and ventilation analysis solutions aimed at improving the diagnosis and management of lung disease in clinical and research settings.
Average Trading Volume: 7,737,993
Technical Sentiment Signal: Buy
Current Market Cap: A$3.19B
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.